|
Press Releases |
|
|
|
Tuesday, December 15, 2020 |
|
德琪醫藥中長線價值俱佳 未來兩年陸續收成 |
中國生物科技股行業前景佳,市場對創新醫藥的需求隨著醫療服務質量的持續提升而擴大,尤其在抗腫瘤及免疫系統相關治療領域,未來市場新增需求更有望迎來黃金機遇。 more info >> |
|
Friday, November 20, 2020 |
|
覆蓋亞太地區的一體化創新腫瘤藥公司德琪醫藥有限公司於香港聯合交易所主板掛牌 |
德琪醫藥有限公司(「德琪醫藥」或「公司」,連同其附屬公司,統稱「集團」;股份代號:6996.HK),一家面向亞太、佈局全球,集新藥開發、臨床研究於一體的臨床階段生物醫藥公司,今天於香港聯合交易所有限公司(「港交所」)主板正式掛牌並開始交易。 more info >> |
|
Antengene Corporation Successfully Listed on Main Board of SEHK |
Antengene Corporation Limited ("Antengene" or the "Company", together with its subsidiaries, the "Group", stock code: 6996.HK), a clinical-stage biopharmaceutical company with integrated drug discovery, clinical development, anchored in Asia-Pacific (APAC) with a global layout, is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. more info >> |
|
Monday, July 20, 2020 |
|
德琪醫藥C輪融資9700萬美元,主要用於新藥研發和商業化 |
專注於研發和商業化腫瘤領域全新機制及同類最優創新藥的領導企業——德琪醫藥,今日宣佈完成9700萬美元C輪融資。 more info >> |
|
德琪医药C轮融资9700万美元,主要用于新药研发和商业化 |
专注于研发和商业化肿瘤领域全新机制及同类最优创新药的领导企业——德琪医药,今日宣布完成9700万美元C轮融资。 more info >> |
|
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization |
Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Ordify Employs Blockpass to Open Investment to Everyone
May 3, 2024 13:38: JST
|
|
|
Singapore's top general insurer debuts trading on Asia's leading digital exchange, AltaX
May 3, 2024 10:30 HKT/SGT
|
|
|
Nephros Schedules First Quarter 2024 Financial Results Conference Call
May 3, 2024 08:31 HKT/SGT
|
|
|
Nass Valley Gateway Ltd Announces It Will File Its 2023 EOY Audited Financials by June 28th, 2024, Within the Extension Granted by the BCSC
May 3, 2024 08:26 HKT/SGT
|
|
|
UPDATE: Kaplan Fox Files Class Action to Recover Losses for Investors Who Were Short The Barclays Bank PLC iPath Series B S&P 500 VIX Short-Term Futures ETN (CBOE: VXX) ("VXX")
May 3, 2024 08:05 HKT/SGT
|
|
|
长江电力公布2023年年度业绩 营收利润双增长
May 2, 2024 23:00 HKT/SGT
|
|
|
長江電力公佈2023年年度業績 營收利潤雙增長
May 2, 2024 22:54 HKT/SGT
|
|
|
SMEStreet Celebrates 10 Years of Serving Indian MSMEs
May 2, 2024 22:20 HKT/SGT
|
|
|
Hong Kong International Licensing Show creates cross-industry business opportunities
May 2, 2024 21:18 HKT/SGT
|
|
|
CITIC Telecom CPC Garners Multiple Ecosystem Partners Awards Reinforces Collaborative Capabilities, Drives Breakthrough Innovation & Shares Sustainable Development Results
May 2, 2024 21:17 HKT/SGT
|
|
|
INNIO Group's 2023 Sustainability Report: Progress in Implementing Corporate Sustainability Goals
May 2, 2024 21:16 HKT/SGT
|
|
|
FTLife Pre-Announces Name Change to Chow Tai Fook Life Insurance Company Limited
May 2, 2024 21:15 HKT/SGT
|
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
May 2, 2024 22:13 JST
|
|
|
Loop Industries and Ester Industries Ltd. Announce Joint Venture Agreement to Build an Infinite Loop(TM) Manufacturing Facility in India
May 2, 2024 21:12 HKT/SGT
|
|
|
SDAI Limited: Positive Outcomes Since New Board took over in June 2023
May 2, 2024 21:00: JST
|
|
|
|
More News >> |
|
|
|
|
|